Ignite Creation Date:
2024-05-06 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05165433
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-02
First Post:
2021-12-07
Brief Title:
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours FORTIFY
Sponsor:
Akamis Bio
Organization:
Akamis Bio
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-23
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-07
First Submit QC Date:
December 7 2021
Study First Post Date:
2021-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-06
Last Update Post Date:
2023-08-02
Last Update Post Date Type:
ACTUAL